Zeliha DİŞLİ KORKMAZ, Hülya GÜNDOĞDU, Almıla Gülsün PAMUK, Ülkü AYPAR

İKİ OLGUDA CİVA ZEHİRLENMESİNİN ETKİLERİ

Civa sıvı halde bulunan ve oda ısısında buharlaşabilen tek metaldir. Zehirlenmesinde, ciltte irritasyon, koagülasyon, korozyon, ağızda ve f arenkste şiddetli duyarlılık, metalik tat, salivasyon, ateş, baş ağrısı, kas ağrısı, bulantı kusma, ishal, karın ağrısı, kimyasal pnömoni, ve nöropsikiyatrik bulgular görülebilir. Civanın etkisi, akut olabileceği gibi, çok sinsi ve uzun sürede de ortaya çıkabilir. Hastanın tedavisine akut dönemde başlanmazsa hasta kronik semptomlarla gelebilir. Biz bu yazıda civadan zehirlenen iki olgunun tanı ve tedavisindeki gecikmeden dolayı ağırlaşan semptomları ve yoğun bakımdaki takip ve tedavilerinde dikkat edilmesi gereken noktaları gözden geçirmeye çalıştık.

EFFECTS OF MERCURY POISONING IN TWO CASES

Mercury is the only metal f ound in liquid f orm and can be vaporised in room temperatures. Mercury may show irritation, coagulation or corrosion, salivation, burning sensation in mouth and pharynx, f ever, headache and muscle ache, metallic taste, nausea and vomiting, diarrhea and abdominal cramps, chemical pneumonitis and neuropsychiatric semptoms. Mercury may eff ect human health very openly and severely, or sometimes very sinisterly and slowly. A patient who does not seek medical help or does not receive proper management in the acute phase may present with chronic symptoms. This case report f ocuses on the symptoms presented by two cases with delayed diagnosis and their f ollow-up and care.

___

1. Caravati EM, Erdman AR, Christianson G et al. American Association of Poison Control Centers: Elemental mercury exposure: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2008; 46: 1-21.
2. Kales SN, Goldman RH. Mercury exposure: current concepts, controversies, and a clinics experience. J Occup Environ Med 2002; 44: 143-154.
3. Clifton JC. Mercury exposure and public health. Pediatr Clin North Am 2007; 54 : 237269.
4. Shandley K, Austin DW; Ancestry of pink disease (infantile acrodynia) identified as a risk factor for autism spectrum disorders. J Toxicol Environ Health A. 2011;74: 1185-1194.
5. Scoville SA, Lane OP. Cerebellar abnormalities typical of methylmercury poisoning in a fledged saltmarsh sparrow, Ammodramus caudacutus. Bull Environ Contam Toxicol. 2013; 90: 616-620.
6. Yilmaz C, Okur M, Geylani H ve ark. Chronic mercury poisoning: Report of two siblings Indian J Occup Environ Med. 2010; 14: 17-19.
7. Counter SA, Buchanan LH. Mercury exposure in children: a review. Toxicology and Applied Pharmacology 2004; 198:209-230.
8. John F. Fisher, Sherlita N. Amler. Mercury exposure: Evaluation and intervention the inapropriate use of chelating agents in the diagnosis and the treatment of putative mercury poisining. NueroToxicology 2005; 26: 691-699
9. Wössmann W, Kohl M, Grüning G, Bucsky P. Mercury intoxication presenting with hypertension and tachycardia. Arch Dis Child 1999; 80: 556-557.
10. Sillenberg EK, Silva IA, Nyland JF. Mercury and autoimmunity: implications for occupational and environmental health. Toxicol Appl Pharmacol 2005; 207: 282-292.
11. Sarikaya S, Karcioglu O, Ay D, Cetin A ve ark. Akut civa zehirlenmesi: Olgu sunumu BMC Emergency Medicine 2010; 10:7.
12. Olsson GL. Nurophatic Pain in children. In: McGrath PJ, Finlay GA, eds. Chronic and recurrent pain in children and adolescents. Progress in Pain Research and Management. Seattle, WA: IASP Pres. 2004;75-95.
13. Dworkin RH, OConnor AB, Backonja M et all. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007;132:237-251.
14. Dayıoğlu M, Tuncer S, Reisli R. Nöropatik ağrılı bir çocukta gabapentin kullanımı. Ağrı 2008; 20: 37-40.